Language Disturbances as Side Effects of Topiramate and Zonisamide Therapy

Epilepsy and Behavior

Volumn 2, Issue 6, 2001, Pages 579-584

  Ojemann, Linda M ^a   Ojemann, George A ^a   Dodrill, Carl B ^a   Crawford, Carol A ^b   Holmes, Mark D ^a   Dudley, Donald L ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Tyler Communications   (United States)

Author keywords

Anomia; Antiepileptic drug toxicity; Aphasia; Epilepsy; Sanguage; Sulfa; Topiramate; Zonisamide

Indexed keywords

EID: 0000278985     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2001.0285     Document Type: Article

References (22)

1. Aldenkamp A P, Alpherts W CJ, Sandstedt P. Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation. Epilepsia. 39:1998;1070-1074.
2. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia. 36:1995;S46-S65.
3. Massagli T L. Neurobehavioral effects of phenytoin, carbamazepine, and valproic acid: implications for use in traumatic brain injury. Arch Phys Med Rehabil. 72:1991;219-226.
4. Meador K J, Loring D W, Moore E E. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology. 45:1995;1494-1499.
5. Vermeulen J, Aldenkamp A P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res. 22:1995;65-95.
6. Martin R, Kuzniecky R, Ho S, Hetherington H, Pan J, Sinclair K, Gilliam F, Faught E. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999:52(2):321-7.
7. Wilensky A J, Friel P N, Ojemann L M, Dodrill C B, McCormick K B, Levy R H. Zonisamide in epilepsy: a pilot study. Epilepsia. 26:1985;212-220.
8. Ojemann L M, Crawford C A, Dodrill C B, Holmes M D, Kutsy R, Ojemann G A. Language disturbance as a side effect of topiramate and zonisamide therapy. Epilepsia. 40:1999;66.
9. Benton A L, Hamsher Kde S. Multilingual Aphasia Examination: manual of instructions. 1974.
10. Dodrill C B. A neuropsychological battery for epilepsy. Epilepsia. 19:1978;611-623.
11. Reitan R M, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: theory and clinical interpretation. 1993.
12. Ojemann G A, Dodrill C B. Verbal memory deficits after left temporal lobectomy for epilepsy: mechanism and intraoperative prediction. J Neurosurg. 62:1985;101-107.
13. Thompson P J, Baxendale S A, Duncan J S, Sander J W. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry. 69:2000;636-641.
14. McCabe P H, Eslinger P J. Abnormal Wada and neuropsychological testing results due to topiramate therapy. Epilepsia. 41:2000;906-910.
15. Berent S, Sackellares J C, Giordani B, Wagner J G, Donofrio P D, Abou-Khalil B. Zonisamide (CI-912) and cognition: results from a preliminary study. Epilepsia. 28:1987;61-67.
16. Dodrill C B. Effects of sulthiame upon intellectual, neuropsychological, and social functioning abilities among adult epileptics: comparison with diphenylhydantoin. Epilepsia. 16:1975;617-625.
17. Potter S. Therapeutics, materia medica and pharmacy. 1931;. p. 501.
18. Hill M E, Gordon C, Situnayake R D, Heath D A. Sulfasalazine-induced seizures and dysphasia. J Rheumatol. 4:1994;748-749.
19. Resor S R, Kutt H. The medical treatment of epilepsy. 1992.
20. Ojemann G A, Mateer C. Human language cortex: localization of memory, syntax and sequential motor-phoneme identification systems. Science. 205:1979;1401-1403.
21. Amaducci L, Sorbi S, Albanese A, Gainotti G. Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes. Neurology. 31:1981;799-805.
22. Glick S D, Ross D A, Hough L B. Lateral asymmetry of neurotransmitters in human brain. Brain Res. 234:1982;53-63.